Apton Biosystems
Pleasanton
About Apton Biosystems
Apton Biosystems develops an optical system designed for sequencing and protein detection, using super-resolution to assess molecules spaced closer than a wavelength of light. It enables biomarker discovery, early disease detection, and therapeutic monitoring, advancing preventive health and precision medicine.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $31.6M
- Funding stage: M&A
- Last round: Series A (Apr 2021)
- Website: aptonbio.com
- Phone: info@aptonbio.com
Industries & Categories
Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/apton-biosystems-459 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.